Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Olympus Corporation
One of the few silver linings in a tumultuous year dominated by a global pandemic was the huge boost given to the diagnostics and telehealth sectors. But while new technologies for rapid testing for COVID-19 and remote monitoring tools dominated the headlines, there were also key developments in robotic surgery, early-stage cancer testing and cardiac arrhythmia treatment. Here are Medtech Insight’s most popular R&D stories in 2020.
After a year like no other for the global medtech industry, 2021 will present a different set of market challenges for device and diagnostic companies.
Olympus’ acquisition of Veran Medical Technologies will strengthen its respiratory portfolio.
Regardless of who wins, China seems to be looking beyond the 3 November US General Election, instead pouring in large resources to elevate its domestic health sector on a par with international standards, creating opportunities and profoundly impacting many areas from novel therapy development to investment decisions.
- Medical Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Surgical Equipment & Devices
- Other Names / Subsidiaries
- ARC Medical Design Ltd
- Gyrus Group PLC
- Spiration Inc.
- Olympus Biotech
- Olympus Optical Co., Ltd.
- Olympus Surgical America
- Image stream Medical, Inc.
- Veran Medical Technologies, Inc.